Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer Patients

RATIONALE: Radium-223-Dichloride (Ra-223) is an alpha-emitter, used to treat bone metastases. Patients with high metastatic burden and/or with increased trabecular bone uptake could present a higher incidence of hematologic toxicity. We hypothesized that these two factors are predictors of bone marr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biomed Res Int
Hlavní autoři: Fiz, Francesco, Sahbai, Samine, Campi, Cristina, Weissinger, Matthias, Dittmann, Helmut, Marini, Cecilia, Piana, Michele, Sambuceti, Gianmario, la Fougère, Christian
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5757096/
https://ncbi.nlm.nih.gov/pubmed/29435457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3905216
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky